Weblog

Monday, 14 December 2009

  • Nearsightedness increasing in the United States

    More Americans are becoming nearsighted, but it is not clear why, U.S. researchers reported on Monday.

    They found more than 40 percent of Americans aged 12 to 54 developed myopia between 1999 and 2004, compared to just 25 percent in 1971 and 1972.

    Their findings, published in the Archives of Ophthalmology, could be important for health policy, given the billions of dollars spent each year in caring for people with myopia.

    The likely cause is less outdoor time and more activities requiring close-up viewing such as text-messaging, playing hand-held video games and Web surfing, said the study’s lead author, Susan Vitale.

     

Friday, 06 November 2009

  • New Treatment for Graves’ eye disease

    Researchers find new treatment mehtod for Graves’ eye disease

    According to University of Michigan, a small group of patients with severe Graves’ eye disease experienced rapid improvement of their symptoms — and improved vision — following treatment with the drug rituximab. Inflammation around their eyes and damage to the optic nerve were significantly reduced. The same patients had not previously responded to steroids, a common treatment for Graves’ eye disease.

    Raymond S. Douglas, M.D., Ph.D., an oculoplastics specialist at University of Michigna, reports on the potential of the drug in the online October issue of Ophthalmology. Douglas reviewed the progress of six patients he treated while on the faculty of the University of California at Los Angeles.
     
    Graves’ eye disease is an autoimmune disease that causes inflammation and fatty deposits in the eye muscles and connective tissue surrounding the eye.
     
    The study suggests that rituximab is a potentially effective new treatment for the most severe forms of Graves’ eye disease.

Thursday, 23 July 2009

  • New Contact Lenses Deliver Drugs

    When you take eye drops, blinking and your natural tears can mean that as little as 1 percent of the drug actually goes into your eye.

    However, when it comes to medication, such reactions are less than favourable and cause as little as 1 to 7 percent of the dose is actually absorbed by the eye.

    To combat this problem, a research team, led by Daniel Kohane, MD, PhD, director of the Laboratory for Biomaterials and Drug Delivery at Children's Hospital Boston, has created special contact lenses that can gradually dispense a constant amount of medication to the eye, at adjustable rates.

    Kohane and colleagues at the Department of Chemical Engineering at the Massachusetts Institute of Technology (MIT) created a two-layer contact lens with an inner drug-bearing biodegradable polymer film known as PLGA.


    In laboratory testing, the prototype lenses dispensed ciprofloxacin (an antibiotic often used in eyedrops) for 30 days, the longest duration for which contact lenses are currently approved by the FDA; in some tests, the lenses continued releasing drug for up to 100 days. The amounts dispensed were sufficient to kill pathogens in a laboratory assay.

    The researchers have started testing the lens in animals and plan to begin human testing as soon as possible.


    (The lens has been described in the July issue of Investigative Ophthalmology and Visual Science. (ANI)|}

    > Learn how to get disposable contact lens

Wednesday, 01 July 2009

  • Contact Lens Giant Bausch & Lomb To Cut Jobs

    Global contact lens and eye care giant Bausch & Lomb is to shed 120 jobs at its south-east plant as it looks to cut costs and shift part of its Irish operation to the US. Skip related content

    It is the second major employment blow for the region in a week, following manufacturing plant ABB's announcement it was closing with the loss of almost 180 staff.

    Bosses at the Waterford plant said they plan shipping some of the contact lens production to the firm's New York headquarters where manufacturing costs are lower.



Wednesday, 17 June 2009

  • FDA urges improved contact lens safety

    Contact lenses ought to be a convenient alternative to awkward or uncomfortable eye glasses, but the inappropriate storage and misuse of contact lens solutions can lead to painful eye infections and even blindness, the Food and Drug Administration reminded consumers.

    The FDA said people who do not follow instructions for contact lens care and use might increase their risk of serious eye infections that can lead to blindness.

    The FDA is again stressing the importance of proper handling and cleaning of contact lenses and advising consumers to always completely empty the solution out of contact lenses after each use.

    To support proper cleaning and storage, the FDA has developed a new video on contact lens safety, which can be found on the FDA's Web site (www.fda.gov), along with an in-depth Consumer Update article.

    Other important lens care tips from the FDA include:

    -- Do not top off or reuse lens cleaning solution.

    -- Use a contact lens solution to clean, rinse, and then air dry contact lens cases after each use.

    -- Do not expose contact lenses or lens storage cases to any type of water or other non-sterile solutions.


    The FDA has now released a public advisory designed to educate contact-lens wearers about the proper care and use of saline solutions in an effort to avoid severe complications.





    Earlier this year, the FDA held a workshop along with eye care professionals to develop a set of guidelines for evaluating contact lens solutions. The FDA is still working on compiling rules for manufacturers and possibly changing labeling for the products to warn users of the potential for injury.

    For more consumer information and tips on contact lens, visit Contac Lens Consumer Guide.

contacts2020

  • Visit contacts2020's Xanga Site
    • Name: Jessie
    • Member Since: 6/8/2009

Archives

Don't worry - your calendar is here… to see it in action just click "Save" above and refresh the page.

About Me

[no info]

Pulse

contacts2020 has no pulse!...

Photostrip

[no photos]